Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: The Star Medicines Importers Co. Ltd., 10, Loukis Akritas Str., 3030 Limassol, Tel: 25 371 056
Xylometazoline belongs to the group of arylalkylimidazolines. It promotes decongestion of the mucous membranes and a reduction in nasal secretions. The effect is rapid and particularly long-lasting.
Carbocistein decreases the viscosity of the secretions and clears the upper respiratory tract.
The spray does not contain a propellent gas and it guarantees an exact dosage and a good distribution.
Triofan is well tolerate and its administration is painless and non-irritating.
No considerable absorption occurs with proper intranasal administration. Should xylometazoline accidentally enter into the gastro-intestinal tract, then absorption would occur rapidly.
Metabolism and elimination data are unknown. Vasoconstriction begins after 3-5 minutes and last approximately 9 hours.
There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the Summary of Product Characteristics.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.